Transition Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

19.10.17	IIROC Trading Halt - BTRU (PR Newswire)
13.10.17	Prime Minister concludes visit to Mexico (PR Newswire)
26.09.17	Target Technologies International Inc. adds TTII COLORBRITE SpectraQuartz colored sand to their line-up of synthetic turf products (PR Newswire)
22.09.17	Tethyan Resources Sets General Meeting of Shareholders (PR Newswire)
21.09.17	Global Greenlights Original Series Private Eyes for a Third Season (PR Newswire)
01.07.16	It's A Ten For Humira, AMPE Drubbed By PIVOT Data, CYNA Awaits Data In Q3 (RTTNews)
30.06.16	OPKO Health Acquires Transition Therapeutics - Quick Facts (RTTNews)
19.04.16	HRTX Abuzz, ILMN Disappoints, STEM Grows, LLY Abandons TTHI's Diabetes Drug (RTTNews)
18.04.16	Transition: Lilly Not To Advance Diabetes Drug Candidate TT401 To Phase 3 (RTTNews)
18.03.16	TTHI, HBIO Put On Notice, Elite Gets FDA Date, VYGR Gets Ready To Sail (RTTNews)
22.06.15	Is A Transition In The Making? (RTTNews)
11.07.14	Transition Therapeutics Names Carl Damiani COO - Quick Facts (RTTNews)
15.05.14	Transition: First Patient Dosed In Phase 2 Study Of TT-401 In Type 2 Diabetes (RTTNews)
21.10.13	Canadians' appetite for mobile banking on the rise (PR Newswire)
07.10.13	Cardiome Announces Publication of Positive Data from an Observational, Retrospective Study of BRINAVESS (PR Newswire)
11.09.13	Transition Therapeutics Announces Fiscal 2013 Year End Financial Results (PR Newswire)
09.09.13	Transition Therapeutics to Hold Conference Call on Full Year Fiscal 2013 Financial Results on Wednesday, September 11th, at 4:30 P.M. EST (PR Newswire)
04.09.13	Transition: First Patient Dosed In Phase 2a Study Of ELND005 In Down Syndrome (RTTNews)
29.08.13	Report de l'entrée en vigueur des nouveaux services en pharmacie - L'AQPP poursuit les négociations avec le MSSS (PR Newswire)
05.08.13	CPRX Back Above $1, STEM Grows, TTHI, IMGN On Watch (RTTNews)
02.08.13	Transition Therapeutics Enters Into a Private Placement with Investors to Receive up to US$21.7 Million in Equity Financing (PR Newswire)
24.07.13	After-market Movers For July 23 (AAPL, EA, VMW, TTHI, ILMN, PNRA, BRCM) (RTTNews)
23.07.13	Transition In-licenses TT-601 From Lilly For Osteoarthritis Pain - Quick Facts (RTTNews)
23.07.13	Transition Therapeutics Enters Osteoarthritis License and Collaboration Agreement with Lilly (PR Newswire)
23.07.13	Increased Demand, Fast Track Designations, and Strong Sales Boost Revenue Growth - Research Report on Alexion, Baxter International, Align Technology, Transition, and OPKO (PR Newswire)
18.07.13	Transition Says FDA Grants Fast Track Status To ELND005 Development Program (RTTNews)
18.07.13	Transition Therapeutics Says FDA Grants Fast Track Designation To ELND005 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	545.60	2.17 %	K V
Sika	235.80	1.51 %	K V
CieFinRichemont	127.65	1.43 %	K V
Part Grp Hldg	1’299.50	1.33 %	K V
Holcim	91.86	1.15 %	K V
Roche Hldg G	254.50	-0.66 %	K V
Lonza Grp	525.00	-0.72 %	K V
Sonova Hldg	297.70	-1.03 %	K V
Alcon	77.12	-1.20 %	K V
Swiss Life Hldg	690.40	-4.69 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Transition Therapeutics IncShs

Aktien Top/Flop

Meistgelesene Nachrichten